Long-term outcomes following functional endoscopic sinus surgery in Samter's triad. by Olivier, F. et al.
Long-term outcomes following functional
endoscopic sinus surgery in Samter’s triad
F OLIVIER1, M GEORGE1, D LEUBA2, P MONNIER1, J P FRIEDRICH2
1Otorhinolaryngology Service, Department of ENT, Head and Neck Surgery, Lausanne University Medical Centre
(CHUV), and 2Otorhinolaryngology Service, Head and Neck Surgery, Hospital of La Chaux-de-Fonds,
Switzerland
Abstract
Objective: This study aimed to assess the long-term outcome of functional endoscopic sinus surgery for Samter’s
triad patients using an objective visual analogue scale and nasal endoscopy.
Method: Using a retrospective database, 33 Samter’s triad patients who underwent functional endoscopic sinus
surgery were evaluated pre- and post-operatively between 1987 and 2007 in Hospital of La Chaux-de-Fonds,
Switzerland.
Results: A total of 33 patients participated in the study, and the mean follow-up period was 11.6 years (range
1.2–20 years). Patients were divided into two groups based on visual analogue scale scores of the five
parameters with the greatest difference in intensity of symptoms between the beginning and end of follow up.
Group 1 included patients with a mean visual analogue scale score of 6 and below at the end of follow up and
group 2 included patients with a mean visual analogue scale score of more than 6. The only statistically
significant difference noted between the two groups was the endonasal findings: stage III–IV polyposis was
present in 1 out of 24 patients (4 per cent) in group 1 and in 5 out of 9 patients (56 per cent) in group 2.
Conclusion: The results of our study indicate that functional endoscopic sinus surgery helps stabilise disease
progression. Stage III–IV polyposis had a significant adverse effect on long-term outcome.
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Introduction
Amino salicylic acid triad, first described by Widal in
1922, is characterised by nasal polyposis, bronchial
asthma and aspirin intolerance. It is also known as
Samter’s triad.1,2 The pathogenesis of this syndrome,
originally described by Szczeklik et al., is thought to
be due to increased activity of the leukotriene synthe-
tase enzyme as a consequence of abnormal arachidonic
acid pathway activity induced by aspirin and other non-
steroidal anti-inflammatory drugs.3 The late onset of
enzyme dysfunction can result from age-related modi-
fications. The leukotrienes LTC4, LTD4 and LTE4
induce mucosal oedema, influx of eosinophils,
bronchospasm and increased mucus secretion into the
airways. A study of 500 patients in Europe revealed
the following sequence: persistent rhinitis, appearing
at a mean age of 29.7± 12.5 years, and then asthma,
aspirin intolerance and, finally, nasal polyposis.
Concerning aspirin intolerance, only 6 per cent of
patients show a positive family history.4
At first, endonasal surgery was considered harmful
for asthma control in Samter’s triad. Later, English
and other surgeons reported good results in patients
who were well stabilised during the peri-operative
period.5 Various reports have shown a beneficial
effect of surgery on the asthma component of the
disease.6 A few reports have described overall encour-
aging functional results after functional endoscopic
surgery (FESS) in Samter’s triad.7–9 However, these
all reported a mean follow up of less than four years.
Vleming et al. showed the importance of correlating
the subjective outcome with post-operative endoscopic
findings.10 They also reported that rhinosinusitis with
nasal polyps represents diseases of different origins
and that the post-surgical outcome may not be compar-
able in patients with and without polyps. Currently,
outcome after sinus surgery is assessed by correlating
post-operative symptoms with endoscopic evaluation
findings.11 Therefore, we aimed to evaluate long-term
outcome using a visual analogue scale (VAS) com-
bined with post-operative nasal endoscopy. It is pos-
sible that correlating these results could identify
predictors of positive outcome in Samter’s triad
patients following FESS.
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Materials and methods
Patients and evaluation
Between 1987 and 2007, we identified 303 patients
who had undergone endoscopic ethmoidectomy for
diffuse nasal polyposis in the Otorhinolaryngology
and Head and Neck surgical clinic, Hospital of La
Chaux-de-Fonds, Switzerland. In this group, 39
Samter’s triad patients were identified (13 per cent).
Of these, 33 were included in this retrospective study
to evaluate subjective general rhinological symptoms
and nasal endoscopic status after a minimum follow
up of one year; six patients were lost to follow up.
Study design
Pre-operative parameters were age at symptom onset,
history of endonasal surgery, surgical complications,
secondary infections, asthma evolution, use of topical
corticosteroids, sequence of Samter’s triad symptoms,
history of smoking, allergies and a family history of
Samter’s triad. Each patient underwent a pre-operative
computed tomography (CT) scan. A patient question-
naire based on a VAS ranging from 0 to 10 (where 0
indicates no discomfort and 10 indicates severe discom-
fort) rated functional impairment on global discomfort,
physical activities, social and professional life, sleep,
nasal obstruction, smell, anterior rhinorrhea, post-nasal
drip, headache, sneezing, epiphora, and facial pain.
The rating for each symptom included status before treat-
ment at our hospital and current status during the last
follow-up visit (range 1.2–20 years).
After functional endoscopic ethmoidectomy, all
Samter’s triad patients underwent meticulous endoscop-
ic suction clearance for several weeks until normal
epithelialisation was found in the sinus cavities. At
the final visit, nasal endoscopy was also performed
to quantify polyposis on a 0–4 scale (Table I). For
each patient, the residual functional impairment and
endoscopic findings were analysed to identify any stat-
istically significant associations with pre-operative
characteristics.
Statistical analysis
Results were analysed using univariate analysis. The
Mann–Whitney U test was used for unpaired
samples and Fischer’s exact test for between-group
comparison. Statistical significance was set at a p
value of 0.05.
Results
In all, 33 patients participated in the study (21 females
and 12 males). The average age at onset was 31.9 years
with a sequence of polyposis to asthma to amino sali-
cylic acid intolerance occurring in 20 patients (61 per
cent), and a sequence of asthma to polyposis to
amino salicylic acid intolerance in 6 patients (18 per
cent). All patients underwent allergy testing and 16
had polyallergies (48 per cent). Twenty-three patients
(70 per cent) underwent complete allergy testing.
After non-steroidal anti-inflammatory drugs, the most
common allergens were pollens, dust mites, cat and
dog hair, and antibiotics. There was a positive family
history of related disease for eight patients (24 per
cent), including asthma in four patients, polyposis in
three and intolerance to aspirin in one. Pre-operative
CT scans showed bilateral sinus opacities in 32 patients
and unilateral disease in 1 patient.
The mean follow-up period was 11.6 years (range
1.2–20 years). Thirteen patients (39 per cent) had a
history of prior surgery before the first intervention in
our hospital, with a total of 49 surgical procedures
(average of 3.8 operations per patient).
A total of 13 patients (39 per cent) needed revision
surgery during the post-operative monitoring period
after an average period of 6.5 years, with a total of 21
operations (1.3 operations per patient). Of these, six
patients underwent revision surgery before the moni-
toring period. Two patients had complications in the
series: one had temporary unilateral cortical blindness
and one had maxillary nerve hypoesthesia.
Follow-up results with proportional distribution are
shown in Table II. The four parameters with
maximum functional impairment were hyposmia
(VAS score 9.3, 6.1), nasal obstruction (VAS score
8.6, 4.2), sleep disturbance (VAS score 5.6, 3.1) and
limited physical activity (VAS score 5.4, 2.7): the
first value corresponds to clinical status before the
intervention and the second value to residual discom-
fort at the end of follow up.
For global discomfort, the initial scale of moderate to
severe discomfort was 6.5 on average, with a third of
patients scoring between 8 and 10 and two-thirds
scoring between 5 and 7. At the end of follow up, the
average VAS score was 3.4, with 2 out of 33 (6 per
cent) patients scoring between 8 and 10, and 9 out of
33 (27 per cent) patients scoring between 5 and 7
(with moderate to severe symptoms), resulting in a
third of patients having mild to moderate symptoms
at the end of monitoring period. The average super-
infection rate during the early follow-up period was
1.7 per year, which later reduced to 0.9 per year.
Patients were divided into two groups based on VAS
scores of the five parameters with the greatest differ-
ence in symptom intensity between the beginning and
end of follow up (overall discomfort, physical activity,
TABLE I
POST-OPERATIVE POLYPOSIS STAGING BASED ON
NASAL ENDOSCOPY
Stage Description
0 No polyp
1 Polypoid mucosa
2 Polyp not extending below the inferior limit of the middle
turbinate
3 Polyp reaching below the middle turbinate but without
extension to the floor of the nasal fossa
4 Polyp in contact with the floor of the nasal fossa
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sleep, nasal obstruction and olfaction). Group 1
included patients with a mean VAS score of 6 or
below at the end of follow up (indicating mild to mod-
erate residual discomfort) and group 2 included patients
with a mean VAS score of greater than 6 (indicating
severe residual symptoms). Regarding these five cri-
teria, the average residual discomfort for the whole
group of 33 patients was evaluated as 3.9. There were
24 patients in group 1 and 9 patients in group 2
(Table II). The only significant difference noted
between the two groups was in the endonasal findings:
there was stage III–IV polyposis in 1 out of 24 patients
(4 per cent) in group 1 and in 5 out of 9 patients (56 per
cent) in group 2. Female predominance was more pro-
nounced in group 2 (7:2, or 78 per cent) than in group
1 (15:7, or 62 per cent), reflecting the greater disease
severity in women.
Although patients with polyallergies were seen
more often in group 2 (6 out of 9; 67 per cent)
than in group 1 (10 out of 24; 42 per cent), statistical
significance was not reached. All patients with a
positive family history belonged to group 1. The
mean follow up exceeded 10 years for both groups.
A decreased incidence of asthma was observed in
13 out of 24 (54 per cent) patients in group 1, and
in 2 out of 9 (22 per cent) patients in group 2. The
mean age at symptom onset was the same for both
groups. The number of secondary infections and revi-
sion surgery during the follow-up period was slightly
higher in group 2 patients. However, the number of
surgical procedures prior to treatment in our hospital
and the total number of interventions were higher in
group 1 patients.
Discussion
Of all the patients who undergo FESS, 10–20 per cent
are reported to have aspirin triad disease.12,13 Long-
term monitoring after endoscopic endonasal ethmoi-
dectomy of Samter’s triad shows significant residual
symptomatology, with an average VAS score of 3.9.
In our case series, patients with advanced polyposis
who underwent FESS experienced a significant level
of severe residual functional impairment (VAS
score>6) at the end of follow up. Asthma symptoms
remained stable or worsened in these patients. This
finding may be explained by the increased inflamma-
tory component of extensive polyposis, altered metab-
olism or reduced responsiveness to topical
corticosteroids in these patients. Primary surgery
should therefore be extensive to avoid the need for revi-
sion and, if necessary, to make it less risky because of
the change to anatomical landmarks. Earlier reports did
not find the rate of revision to be related to the surgical
approach, although the endoscopic technique provided
good results.8,11,12 Our results after long-term monitor-
ing showed an average VAS score of 3.9. Hyposmia
was the predominant residual symptom, followed by
nasal obstruction. Family history of aspirin intolerance
was seen in one patient in our group (3 per cent).
Szczeklik et al. reported a positive family history of
aspirin intolerance in 6 per cent of patients (n= 500),
but this had less impact on disease progression com-
pared with sexual predilection or the presence of
atopy.4 However, in our series, poor prognosis was
related to female sex and the presence of polyallergies,
although the data were not statistically significant.
Amar et al. reported 18 Samter’s triad patients and 22
patients in the control group to have chronic sinusitis
(with or without asthma) after a mean follow up of 3.5
years.7 A history of prior surgery was noted in 11 out
of the 18 Samter’s triad patients and in 6 out of 22
patients in the control group. Revision surgery was
needed for seven patients in the Samter’s triad group
and for two in the control group; the difference was stat-
istically significant. The post-operative symptoms evalu-
ated included pain, nasal obstruction, anosmia and
rhinorrhea. The only significant difference in variables
between groups was hypo-anosmia, which was present
in 89 per cent of Samter’s triad patients and 50 per
cent of patients in the control group. McFadden et al.
reported that in a group of 80 Samter’s triad patients,
bilateral sinus surgery by either a conservative or
radical approach led to improved sinus symptoms and
asthma in 85 per cent and 83 per cent of the patients,
respectively, with an average follow-up of 3 years.8
The same group also reported that of 25 Samter’s triad
patients who underwent surgery for sinusitis with a
mean follow up of 3.4 years, those who underwent
radical surgery showed better symptom resolution, thus
obviating the need for further surgery.9 Although these
TABLE II
CHARACTERISTICS OF SAMTER’S TRIAD PATIENTS,
STRATIFIED BY VAS SCORE
Characteristics Total Group 1∗ Group 2†
n 33 24 9
Previous surgery (n (%)) 12 (39) 11 2
Mean age of onset (y) 31.90 31.67 32.44
Female (n (%)) 21 (64) 15 (62) 7 (78)
Mean follow up (y) 11.6 10.7 13.8
Outcome (n (%))
– Polyallergy 16 (48) 10 (42) 6 (67)
– Endonasal stage III–IV 6 (18) 1 (4) 5 (56)
– Asthma reduction 15 (45) 13 (54) 2 (22)
Global discomfort score
– Pre-op 6.5 6.17 7.44
– Post-op 3.9 2.38 6.11
Physical activity score
– Pre-op 5.39 5.33 5.56
– Post-op 2.73 1.75 5.33
Sleep disorder score
– Pre-op 5.64 5.04 7.22
– Post-op 3.15 1.75 6.89
Nasal obstruction score
– Pre-op 8.61 8.46 9.00
– Post-op 4.21 2.67 8.33
Hyposmia score
– Pre-op 9.33 9.25 9.56
– Post-op 6.12 5.25 8.44
∗VAS score≤6. †VAS score>6. y= years; pre-op= pre-opera-
tive; post-op= post-operative.
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results seem very encouraging, the short follow up sug-
gests that these are interim results, which may show a
better outcome compared with our study that had a
much longer follow up, and in which the first revision
surgery occurred after 6.5 years.
Good asthma control in the peri-operative period pre-
vented decompensation. In our patients, the dose of
topical and systemic steroids was reduced or the disease
was stabilised; these results were similar to those of
Loehrl et al. and Nakamura et al.6,12 To evaluate the sur-
gical treatment of sinusitis in Samter’s triad, Nakamura
et al. studied 22 patients who underwent sinus surgery.
Subjective evaluation indicated that sinus surgery effect-
ively treated asthma in 20 patients (90.9 per cent), with a
mild to marked improvement.12 Good functional results
were noted for nasal obstruction, rhinorrhea, hyposmia
and asthma over a mean follow up of 4 years. Post-
operative tests showed a significant improvement in pul-
monary function over pre-operative tests. These patients
also showed a significant reduction in the dose of system-
ic or topical steroids used after surgery.
Folia et al. reported their experience of treating 203
patients with endonasal endoscopic ethmoidectomy for
nasal polyposis followed by intranasal corticotherapy.13
The patients’ global satisfactory rate for this medico-sur-
gical approach of treating the disease was 93.6 per cent.
A positive correlation was found between severe olfac-
tory disorders and the administration of oral cortico-
steroid therapy. No deterioration or improvement in
asthma was seen in 92 per cent of these patients. In 65
patients with nasal polyposis refractory to intensive
medical management, Dufour et al. noted a good
improvement in patient quality of life following endo-
scopic sphenoethmoidecomy.14,15 They also noted a
reduction in the required anti-asthmatic medication
dosage for 24 out of 31 patients. Aspirin desensitisation
was not observed in any patient in our series, although
previous reports support a role for aspirin desensitisation
treatment in aspirin-sensitive patients with rhinosinusitis
and asthma.16,17 McMains and Kountakis reported that
revision FESS has beneficial effects in Samter’s triad
patients.18 They also showed that aspirin desensitisation
can decrease the likelihood of additional surgical inter-
vention over a two-year period. A family history of
aspirin triad disease was not found in our patients,
although a hereditary aetiology has been reported.5,6
• Samter’s triad is characterised by nasal
polyposis, bronchial asthma and amino
salicylic acid intolerance
• Long-term outcome after functional
endoscopic sinus surgery was assessed using a
visual analogue scale and nasal endoscopy
• Functional endoscopic sinus surgery helped
stabilise the disease
• Stage III–IV polyposis had a significant
adverse effect on long-term outcome
By acting as receptor antagonists, anti-leukotrienes
have been reported to have a role in controlling post-
surgical nasal polyposis. Effective control of asthma
was seen and stabilisation of sinonasal polyposis was
achieved in some patients by treatment with anti-leuko-
trienes.19–21 However, these drugs were not used in this
study.
Conclusion
Long-term monitoring after endoscopic endonasal eth-
moidectomy for Samter’s triad showed an average VAS
score of 3.9 (on a 0–10 scale). Our results therefore
support a current management strategy of combination
therapy comprising both medical and surgical therapy
for Samter’s triad. Our study findings indicate that
endoscopic sinus surgery in Samter’s triad patients
helps stabilise the disease.
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